Thursday, 10 September 2015

08:00

Registration

09:00

Inauguration


Session I: Plenary Session (Combined Session in Summit II)

09:15

Ahmed KamalKeynote Presentation

Development of New Molecules as Potential Anticancer Agents
Ahmed Kamal, Outstanding Scientist and Head, Indian Institute of Chemical Technology, India

10:00

Amitabha ChattopadhyayKeynote Presentation

Role of Host Membrane Cholesterol in Pathogen Entry: A Tale of Two Pathogens
Amitabha Chattopadhyay, Outstanding Scientist (Director Level), Centre for Cellular & Molecular Biology, India

10:45

ThermoFisher ScientificTechnology Spotlight:
Accelerate Your Drug Discovery Process with Maybridge Screening Collections and Fragment Libraries
Simon Pearce, Global Product Manager, ThermoFisher Scientific

11:05

eDiscovery Automation Pvt LtdTechnology Spotlight:
Automation Tools for Drug Discovery
Basavaraj Gadag, Director, eDiscovery Automation Pvt Ltd

11:20

Coffee Break and Networking in Exhibition Area


Session II: Design and Synthesis of Pharmaceutically Relevant Novel Molecules

11:50

Anamik ShahKeynote Presentation

Design and Synthesis of Pharmaceutically Relevant Novel Molecules.
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India

12:35

Scaffold Mimetic and Modeling for New Molecule Design and Synthesis
Ashoke Sharon, Associate Professor, Birla Institute of Technology Mesra, India

13:10

Tandem Synthesis of Pharmaceutically Relevant Molecules: An Insight into the Synthesis of Deuterated Small Molecules
Akhilesh Verma, Professor, University of Delhi, India

13:45

Lunch Break and Networking in Exhibition Area


Session III: Novel Approaches to Drug Discovery

14:45

Prabhat AryaKeynote Presentation

Building New Research Models for Next Generation Drug Discovery
Prabhat Arya, Professor and Head, Dr Reddy's Institute of Life Sciences, India

15:30

Structure-Based Design of Inhibitors of the Biosynthesis of Aromatic Amino Acids – Opportunities for Drug Discovery
Concepción González-Bello, Professor, Universidad de Santiago de Compostela, Spain

16:05

Epigenetics in Cancer Drug Discovery: Reading the Right Mark
Susanta Samajdar, Vice President - Medicinal Chemistry, Aurigene Discovery Technologies Limited, India

16:40

Coffee Break and Networking in Exhibition Area


Session IV: Current Trends in Medicinal Chemistry I

16:55

Drug Metabolism and Toxicity Studies Using Theoretical Chemistry Methods
Prasad Bharatam, Professor, NIPER Mohali, India

17:30

Perspectives and Challenges in Drug Research: Design and Synthesis of Nitrogen Heterocycles as Novel therapeutic Agents
Prem M S Chauhan, Professor (AcSIR), Central Drug Research Institute, India

18:05

End of First Day of Conference

Friday, 11 September 2015


Session V: Current Trends in Medicinal Chemistry II

08:55

Jonathan BaellKeynote Presentation

Why Can’t We Discover Good Histone Acetyltransferase Inhibitors?
Jonathan Baell, Professor , Monash University, Australia

09:30

Pentraxins: A New Class of Potential Proteins in the Treatment of Tuberculosis
Prati Pal Singh, Professor, NIPER Mohali, India

10:05

Diverse Synthesis of Natural Product Inspired Fused and Spiro-Heterocyclic Scaffolds Via Ring Distortion and Construction Strategy
Subhabrata Sen, Associate Professor, Shiv Nadar University, India

10:35

Coffee Break and Networking in Exhibition Area


Session VI: Computational Approaches in Medicinal Chemistry

11:05

Quantum Medicinal Chemistry in the design of Anti-malarial agents
Prasad Bharatam, Professor, NIPER Mohali, India

11:40

Role of Chemoinformatics for Virtual Screening in Drug Discovery
Muthukumarasamy Karthikeyan, Principal Scientist, National Chemical Laboratory, India

12:15

Specific and Non-Specific Cellular Responses from Redox-Active Heterocycles: Dihydroquinolines as promising Scaffolds for ‘Multi-targeting’
K M Muraleedharan, Associate Professor, Indian Institute of Technology Madras, India

12:50

Poster Viewing

13:10

Lunch Break and Networking in Exhibition Area


Session VII: Current Trends in Enanioselective Synthesis & Catalysis

14:10

Vinod Kumar KansalKeynote Presentation

Current Trends in Enantioselective Synthesis & Catalysis
Vinod Kumar Kansal, President - R & D, Teva API India Ltd, India

14:55

Current Trends in Enantioselective Synthesis & Catalysis
Rodney Fernandes, Professor, Indian Institute of Technology Bombay, India

15:30

Asymmetric Supramolecular-Organocatalysis: Scope and Applications
Dhevalapally B Ramachary, Professor, University of Hyderabad, India

16:05

Coffee Break and Networking in Exhibition Area

16:20

Session VIII: Panel Discussion : Driving Medicinal Chemistry towards Drug Discovery & Development